Allan Reine, MD
Allan Reine, MD, joined Foghorn Therapeutics in 2019 as chief financial officer. He has more than 10 years of financial experience in the biotechnology and pharmaceuticals industry.
Prior to joining Foghorn, Allan was chief financial officer at Pieris Pharmaceuticals, Inc. Throughout his career, Allan has managed various healthcare portfolios focused on biotechnology and pharmaceutical companies at Lombard Odier Asset Management, Citi Principal Strategies, SAC Capital Advisors, Trivium Capital and Alexandra Investment Management. He started his career at CIBC World Markets where he worked in both biotechnology investment banking and biotechnology equity research.
Allan received his MD from the University of Toronto, and his Bachelor of Science in statistical sciences from the University of Western Ontario.